Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
This piece breaks down why Total Market Return 2024 matters, highlighting drivers, risks, and practical steps to align holdings with your goals.
28,491 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Rising longevity, tax complexity, and market volatility are forcing retirees to rethink the old retirement playbook. ...
Bitcoin struggles to clear the $90K barrier as four market forces converge. Analysts say a sustained weekly close abo...
As June approaches, Netflix stock may be on the radar for investors seeking a rebound. This article highlights three ...
Bitcoin climbs after Trump suggests an Iran deal is near, sparking a risk-on move in crypto markets. Prices hit aroun...
The FHFA has asked Congress for sweeping new authority to file civil lawsuits for mortgage fraud, aiming to curb abus...
Boards of public homebuilders are treating scale as a fiduciary test, a shift highlighted by Berkshire Hathaway's Tay...
Analysts see value in Nvidia-backed AI infrastructure bets after last week’s pullback, highlighting dip-buy opportuni...
Solana’s SOL is hovering near a key $95 zone as traders watch for a breakout. Fresh data show rising volumes and a ti...
Bright Horizons beats earnings estimates but unveils a larger-than-expected 2026 center-closure plan, sending bfam sh...
Snap faces another disappointing quarter as ad revenue slows and user growth stalls. With mounting headwinds, many an...
Bitcoin fell to a two-week low as leveraged bets were wiped out and risk appetite faded amid geopolitical tensions an...